A pair of fighters who competed earlier this month in Las Vegas have failed their post-fight drug tests, according to a report by MMAjunkie.com.
Kevin Casey, who defeated Bubba Bush via first round knockout at UFC 175, tested positive for drostanolone. Robert Drysdale, a winner over Keith Berish at The Ultimate Fighter 19 Finale the same weekend, had 12-to-1 elevated testosterone-to-epitestosterone levels.
Casey, a former competitor on The Ultimate Fighter, failed his first drug test, while it was the second for Drysdale. Both fighters were temporarily suspended and will likely be fined and have their wins overturned to no-contests.
The UFC has released an official statement, saying, “The UFC has been notified by the Nevada State Athletic Commission that UFC middleweight Kevin Casey and light heavyweight Robert Drysdale failed drug tests following their fights at UFC 175 and The Ultimate Fighter Finale, respectively. Casey tested positive for drostanolone and Drysdale was flagged for an elevated testosterone-to-epitestosterone ratio,.
“Both fighters have been temporarily suspended from competition and informed their positive tests violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes and will support the NSAC’s determination pending a formal hearing at a later date.”